<html><head><link rel="stylesheet" href="sl2style.css" type="text/css"></head><body bgcolor="#FFFFFF"><font face="Arial">
<table id=SL2ITTAB width="100%">
<tr><td width="5%">&nbsp;</td><td width="10%">&nbsp;</td><td width="70%">&nbsp;</td><td width="15%" id=SB>07.11.2003</td></tr>
<tr><td width="5%"></td><td id=SL2ITL1 width="10%"><a href="IT06.htm">06.</a></td><td id=SL2ITL1 width="70%">BLUT - SANG</td><td width="15%"></td></tr>
<tr><td width="5%"></td><td id=SL2ITL2 width="10%"><a href="IT06.htm">06.07.</a></td><td id=SL2ITL2 width="70%">Antianaemica - Antianaemica</td><td width="15%"></td></tr>
<tr><td width="5%"></td><td id=SL2ITL3 width="10%"><a href="IT06.htm">06.07.30.</a></td><td id=SL2ITL3 width="70%">Andere - Autres</td><td width="15%"></td></tr>
</table>
<table id=SL2P width="100%">
<tr><td width="15%"></td><td id=SL2PRNAME width="35%">Aranesp</td><td id=SL2PARTN width="49%"><A HREF="PRT487.HTM">AMGEN SWITZERLAND AG</A></td><td width="1%"></td></tr></table>
<table id=SL2SUB width="100%">
<tr><td width="5%"></td><td width="10%"></td><td width="70%" id=SL2SUB1>(Darbepoetin. alfa)</td><td width="15%"></td></tr>
</table>
<table id=SL2PR width="100%">
<tr><td id=SL2PRLIM width="5%">(L)</td><td width="10%"></td><td id=SL2PRNAME width="85%">Amp. 10 mcg </td></tr></table>
<table id=SL2PRLIMT width="100%">
<tr><td width="5%"></td><td width="10%"></td><td width="70%" id=SL2PRLLINE><b><sup></sup>Limitatio:</b> Renale Anämie bei Niereninsuffizienz.
 <br>Anémie rénale lors d'une insuffisance rénale.
<br>Anemia renale nel caso di un'insufficienza renale.
</td><td width="15%"></tr>
<tr><td width="5%"></td><td width="10%"></td><td width="70%" id=SL2PRLLINE><b><sup></sup>Limitatio:</b> Behandlung der symptomatischen Anämie (Hb < 10,5 g/dl) bei erwachsenen Patienten/innen mit soliden Tumoren, bei welchen eine Chemotherapie über eine Mindestdauer von 2 Monaten vorgesehen ist.<br>Traitement de l'anémie symptomatique (Hb < 10,5 g/dl) chez les patients adultes atteints de tumeurs solides, pressentis pour une chimiothérapie pendant une durée minimum de deux mois.<br>Trattamento di anemia sintomatica (Hb < 10,5 g/dl) in pazienti adulti colpiti da tumori solidi, per i quali è prevista una chemioterapia della durata di almeno due mesi.</td><td width="15%"></tr>
</table>
<table id=SL2PK width="100%">
<tr><td width="5%" id=SL2PKLIM></td><td width="10%" id=SL2BSVD>17807</td><td width="25%" id=SL2PKBEZ>4 Amp. ad iniect. parat. 10 mcg</td><td align="right" width="13%" id=SL2PRICE>199.60</td><td align="right" width="12%" id=SL2PRICE_I>{155.60}</td><td width="25%" id=SL2IKS>[55725 004] <a href="http://www.pharmavista.net/scripts/api.dll?pgm=CDQ32&cmd=C2D17D0&par0=PH&match0=2591301">(259 13 01)</a></td><td width="10%" id=SL2AUFN>01.11.2002, A</td></tr>
</table>
<table id=SL2PR width="100%">
<tr><td id=SL2PRLIM width="5%">(L)</td><td width="10%"></td><td id=SL2PRNAME width="85%">Amp. 15 mcg </td></tr></table>
<table id=SL2PRLIMT width="100%">
<tr><td width="5%"></td><td width="10%"></td><td width="70%" id=SL2PRLLINE><b><sup></sup>Limitatio:</b> Renale Anämie bei Niereninsuffizienz.
 <br>Anémie rénale lors d'une insuffisance rénale.
<br>Anemia renale nel caso di un'insufficienza renale.
</td><td width="15%"></tr>
<tr><td width="5%"></td><td width="10%"></td><td width="70%" id=SL2PRLLINE><b><sup></sup>Limitatio:</b> Behandlung der symptomatischen Anämie (Hb < 10,5 g/dl) bei erwachsenen Patienten/innen mit soliden Tumoren, bei welchen eine Chemotherapie über eine Mindestdauer von 2 Monaten vorgesehen ist.<br>Traitement de l'anémie symptomatique (Hb < 10,5 g/dl) chez les patients adultes atteints de tumeurs solides, pressentis pour une chimiothérapie pendant une durée minimum de deux mois.<br>Trattamento di anemia sintomatica (Hb < 10,5 g/dl) in pazienti adulti colpiti da tumori solidi, per i quali è prevista una chemioterapia della durata di almeno due mesi.</td><td width="15%"></tr>
</table>
<table id=SL2PK width="100%">
<tr><td width="5%" id=SL2PKLIM></td><td width="10%" id=SL2BSVD>17807</td><td width="25%" id=SL2PKBEZ>4 Amp. ad iniect. parat. 15 mcg</td><td align="right" width="13%" id=SL2PRICE>291.25</td><td align="right" width="12%" id=SL2PRICE_I>{233.40}</td><td width="25%" id=SL2IKS>[55725 008] <a href="http://www.pharmavista.net/scripts/api.dll?pgm=CDQ32&cmd=C2D17D0&par0=PH&match0=2591318">(259 13 18)</a></td><td width="10%" id=SL2AUFN>01.11.2002, A</td></tr>
</table>
</body></html>
